Skip to main content

Table 6 Treatment progress and changes in the serum carcinoembryonic antigen (CEA) level among different stages

From: Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment

Stage

Baseline CEA levels

Post CEA levels

P*

Decreased

P†

Decreased > 20%

P†

All patients

2.45 (1.46, 5.20)

2.42 (1.63, 4.21)

0.651

264 (49.53)

0.335

190 (35.65)

0.027

0

2.86 (1.3, 13.67)

2.41 (1.61, 4.05)

0.303

18 (52.94)

 

16 (47.06)

 

I

2.23 (1.55, 3.98)

2.33 (1.64, 3.97)

0.973

43 (41.75)

 

26 (25.24)

 

II

2.37 (1.38, 5.07)

2.30 (1.60, 3.98)

0.793

79 (49.69)

 

53 (33.33)

 

III

2.58 (1.48, 7.1)

2.52 (1.65, 4.68)

0.923

124 (52.32)

 

95 (40.08)

 
  1. *P value for Wilcoxon test; †P value for chi-square test
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us